Increased Fetal Cardiovascular Disease Risk: Potential Synergy Between Gestational Diabetes Mellitus and Maternal...

Area of Science:

• Obstetrics and Gynecology
• Cardiology
• Developmental Biology

Background:

• Cardiovascular diseases (CVD) are a leading global cause of death.
• Maternal metabolic conditions, including gestational diabetes mellitus (GDM) and maternal supraphysiological hypercholesterolemia (MSPH), are linked to increased fetal CVD risk.
• GDM involves hyperglycemia, inflammation, and insulin resistance, impacting fetal nutrient exposure and endothelial function.
• MSPH is characterized by elevated cholesterol, leading to endothelial dysfunction and altered fetal nutrient transport.

Purpose of the Study:

• To explore the cellular mechanisms linking maternal metabolic diseases to fetal cardiovascular disease risk.
• To investigate the combined effects of GDM and MSPH on placental function and fetal development.
• To highlight the need for further research into the separate and cumulative roles of GDM and MSPH.

Main Methods:

• This study is a review of existing evidence and a theoretical exploration of cellular processes.
• Analysis of the impact of GDM and MSPH on placental nutrient transport and endothelial function.
• Examination of the potential synergistic effects of co-occurring GDM and MSPH.

Main Results:

• Both GDM and MSPH independently impair endothelial vascular tone and alter nutrient transport to the fetus.
• The simultaneous occurrence of GDM and MSPH may synergistically exacerbate placental dysfunction and endothelial damage.
• Current understanding of the cellular processes underlying these associations, especially in combination, is limited.

Conclusions:

• Maternal GDM and MSPH represent significant risk factors for fetal cardiovascular health.
• The combined presence of GDM and MSPH may pose a synergistic threat to fetal cardiovascular development.
• Further research is crucial to elucidate the specific cellular pathways involved and to develop targeted interventions.